Product image of Zercepac (Trastuzumab) supplied by GNH India

Zercepac

Active Ingredient:
Trastuzumab
Origin:
EU

Zercepac (Trastuzumab)

Zercepac (trastuzumab) is a monoclonal antibody therapy used in cancer treatment. This EU-sourced intravenous infusion targets HER2-positive tumor cells. It is prescribed under medical supervision for specific oncology indications. Always consult a healthcare provider for personalized guidance.

Manufacturer / TM Owner

Accord Healthcare S.L.U.

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

Indications & Clinical Uses

  • Trastuzumab is primarily used to treat HER2-positive breast cancer and HER2-positive metastatic gastric or gastroesophageal junction adenocarcinoma. It may be administered alone or combined with other cancer therapies like chemotherapy. This medication works by binding to HER2 receptors to slow or stop cancer cell growth. Patients often ask, 'What is trastuzumab used for?' in relation to these approved oncology indications.

Side Effects

  • As a targeted therapy, trastuzumab helps reduce tumor size and progression in HER2-positive cancers. Many patients experience stabilization of disease or improved response to treatment when combined with other therapies. Common effects include infusion-related reactions such as fever, chills, or fatigue during administration. These effects are typically monitored by healthcare professionals during therapy sessions.

Precautions & Warnings

  • Trastuzumab requires careful administration under medical supervision due to potential infusion reactions. Patients with pre-existing heart conditions should discuss risks with their doctor before starting treatment. Regular cardiac monitoring may be recommended during therapy. Healthcare providers will assess suitability based on individual health profiles and cancer stage.

Avoid Interactions

  • Trastuzumab may interact with other medications, including anthracyclines and certain chemotherapy drugs, which can affect heart function. Combining it with other HER2-targeted therapies should be managed by a healthcare team. Patients should inform their doctor about all medications, supplements, or herbal products they are using. Close monitoring helps mitigate potential risks during combined therapies.

Frequently Asked Questions

Trastuzumab is used to treat HER2-positive breast cancer and certain HER2-positive stomach cancers. It targets cancer cells that overexpress the HER2 protein.

Trastuzumab is given as an intravenous infusion under medical supervision. The dosing schedule depends on the treatment plan and cancer type.

Common side effects include fever, chills, nausea, and fatigue, especially during or after infusion. Heart function may also be monitored during treatment.

Yes, trastuzumab is often combined with chemotherapy or hormone therapy. Your healthcare provider will determine the appropriate combination for your condition.

Zercepac is manufactured by Accord Healthcare S.L.U. and sourced from the European Union. It meets EU regulatory standards for pharmaceuticals.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Trastuzumab

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT